Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to assess early markers of cardiovascular disease in women with
polycystic ovary syndrome in use of oral contraceptive containing ethynilestradiol and
chlormadinone acetate alone or associated with Spironolactone.